U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H23NO2.ClH
Molecular Weight 297.82
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HEXYLCAINE HYDROCHLORIDE

SMILES

Cl.CC(CNC1CCCCC1)OC(=O)C2=CC=CC=C2

InChI

InChIKey=MTFCPNHRBINLRQ-UHFFFAOYSA-N
InChI=1S/C16H23NO2.ClH/c1-13(12-17-15-10-6-3-7-11-15)19-16(18)14-8-4-2-5-9-14;/h2,4-5,8-9,13,15,17H,3,6-7,10-12H2,1H3;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C16H23NO2
Molecular Weight 261.3593
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Hexylcaine hydrochloride, a benzoic acid ester, is a local anaesthetic that has been used for surface anaesthesia of mucous membranes. Local anesthetics produce a transient block of nerve conduction by interfering with sodium channels. This effect of the anesthetic interferes with the development of an action potential across the nerve.

Originator

Curator's Comment: refrence retrieved from http://www.drugfuture.com/chemdata/hexylcaine-hydrochloride.html

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CYCLAINE

Approved Use

Hexylcaine hydrochloride, a benzoic acid ester, is a local anaesthetic that has been used for surface anaesthesia of mucous membranes. Local anesthetics produce a transient block of nerve conduction by interfering with sodium channels. This effect of the anesthetic interferes with the development of an action potential across the nerve.
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
205 μg/mL
5 mL single, intrathecal
dose: 5 mL
route of administration: Intrathecal
experiment type: SINGLE
co-administered:
HEXYLCAINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
13 min
5 mL single, intrathecal
dose: 5 mL
route of administration: Intrathecal
experiment type: SINGLE
co-administered:
HEXYLCAINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
[Experience in the use of Osmocaine (hexylcaine) as a new local anesthetic in otorhinolaryngology].
1961 Nov
A comparison in rat and mouse heart of the ability of several local anesthetics to inhibit monoamine oxidase.
1983
Patents

Patents

Sample Use Guides

Unknown
Route of Administration: Topical
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:28:26 GMT 2023
Edited
by admin
on Fri Dec 15 15:28:26 GMT 2023
Record UNII
V00NQ7SDYI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HEXYLCAINE HYDROCHLORIDE
MART.   MI   ORANGE BOOK   USP-RS   WHO-DD  
Common Name English
2-PROPANOL, 1-(CYCLOHEXYLAMINO)-, BENZOATE (ESTER), HYDROCHLORIDE
Common Name English
Hexylcaine hydrochloride [WHO-DD]
Common Name English
HEXYLCAINE HYDROCHLORIDE [ORANGE BOOK]
Common Name English
1-(Cyclohexylamino)-2-propanol benzoate (ester) hydrochloride
Common Name English
HEXYLCAINE HCL
Common Name English
CYCLAINE
Brand Name English
HEXYLCAINE HYDROCHLORIDE [MI]
Common Name English
HEXYLCAINE HYDROCHLORIDE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
Code System Code Type Description
RXCUI
1546032
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY RxNorm
DRUG BANK
DBSALT000630
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
ChEMBL
CHEMBL1197
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
EPA CompTox
DTXSID6045321
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
SMS_ID
100000086684
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
EVMPD
SUB02518MIG
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
CAS
532-76-3
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
FDA UNII
V00NQ7SDYI
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
MESH
C004954
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
NCI_THESAURUS
C65853
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
MERCK INDEX
m6014
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
208-544-2
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
PUBCHEM
102426
Created by admin on Fri Dec 15 15:28:26 GMT 2023 , Edited by admin on Fri Dec 15 15:28:26 GMT 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY